Six insiders at Aurinia Pharmaceuticals Inc. (AUPH) collectively acquired approximately $24.84 million worth of company stock on June 2, 2026. The purchases were led by Chief Executive Officer Kevin Tang and included significant stakes from Capital Management LLC Tang, a 10% owner.
These transactions saw CEO Kevin Tang purchase a total of 912,208 shares across multiple trades, with a total value of approximately $12.42 million. Capital Management LLC Tang also acquired 912,208 shares for a combined total of $12.42 million.
This cluster of insider buying, involving multiple executives and significant ownership entities, is generally viewed as a strong bullish indicator, suggesting confidence in the company's future prospects from those with direct knowledge of its operations.